Joel Kahn, MD, FACC
Prevention With Joel Kahn, MD
CardiologyDr. Kahn is a summa cum laude graduate of the University of Michigan School of Medicine. He practices cardiology in Detroit, is a clinical professor of medicine at Wayne State University School of Medicine, and specializes in vegan nutrition and heart disease reversal.
-
Mashup Score: 0
Read the full article here
Tweet
-
Mashup Score: 0Metformin use and risk of myeloproliferative neoplasms: a Danish population–based case-control study - 1 month(s) ago
Read the full article here
Tweet
-
Mashup Score: 0
Read the full article here
Tweet-
- For the first time a new study describes the synchronized oscillations during sleep that power the brain’s glymphatic system to help remove ‘waste’ associated with neurodegenerative diseases, via a mouse model.
- Researchers also found that a commonly prescribed sleep aid might suppress those oscillations, disrupting the brain’s waste removal during sleep.
- Looking at all the possible factors that might contribute to potential cognitive decline risk is important, particularly as new research estimates that dementia risk the risk after the age of 55 among Americans has now more than doubled.
-
-
Mashup Score: 0Zero Coronary Artery Calcification: A Promising Value in Acute Chest Pain Evaluation - 1 month(s) ago
Read the full article here
Tweet
-
Mashup Score: 0
Read the full article here
Tweet-
- Largest meta-analysis to date on statins and dementia risk, including 55 studies and more than 7 million patients.
- Statin use linked to lower risks of all-dementia, AD, and VaD.
- Numerous significant subgroup results highlight statins' diverse neuroprotective effects.
- Findings support statins as a public health tool, especially in low-income countries.
-
-
Mashup Score: 0Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial - 1 month(s) ago
Read the full article here
Tweet
-
Mashup Score: 0New study reveals how a 'non-industrialized' style diet can reduce risk of chronic disease - 1 month(s) ago
Read the full article here
Tweet
-
Mashup Score: 0
Read the full article here
Tweet
The Metformin and Dietary Restriction to Prevent Age-Related Morbid Events in People With Metabolic Syndrome (MeMeMe) trial tested whether 1,700 mg/day metformin (MET) with or without a Mediterranean diet (MedDiet) intervention could reduce the cumulative incidence of major noncommunicable diseases in people with metabolic syndrome.